Abstract
Genetic mutation can result in insignificant corneal changes that can simply be incidental findings on exam or can result in defects of enormous visual consequence. The more substantial phenotypes tend to be secondary to mutations that cause changes in gene expression early in embryogenesis. Less devastating mutations are those that cause a slow degeneration over time. In this chapter we will explore both ends of the spectrum and will discuss each disease entity in detail including presenting signs and symptoms as well as the genes responsible for each. We will also highlight corneal diseases that express variability in penetrance as well as those that exhibit allelic and locus heterogeneity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ma AS, Grigg JR, Jamieson RV. Phenotype-genotype correlations and emerging pathways in ocular anterior segment dysgenesis. Hum Genet. 2018.
Ito YA, Walter MA. Genomics and anterior segment dysgenesis: a review. Clin Exp Ophthalmol. 2014;42:13–24.
Rennie CA, Chowdhury S, Khan J, et al. The prevalence and associated features of posterior embryotoxon in the general ophthalmic clinic. Eye (Lond). 2005;19:396–9.
Berry FB, Lines MA, Oas JM, et al. Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis. Hum Mol Genet. 2006;15:905–19.
Seifi M, Walter MA. Axenfeld-Rieger syndrome. Clin Genet. 2018;93:1123–30.
Moyers RE. Handbook of orthodontics for the student and practitioner. 3rd ed. Chicago: Yearbook; 1973.
Bhandari R, Ferri S, Whittaker B, Liu M, Lazzaro DR. Peters anomaly: review of the literature. Cornea. 2011;30:939–44.
Nischal KK, Naor J, Jay V, MacKeen LD, Rootman DS. Clinicopathological correlation of congenital corneal opacification using ultrasound biomicroscopy. Br J Ophthalmol. 2002;86:62–9.
Yang LL, Lambert SR, Lynn MJ, Stulting RD. Surgical management of glaucoma in infants and children with Peters’ anomaly: long-term structural and functional outcome. Ophthalmology. 2004;111:112–7.
Vincent A, Billingsley G, Priston M, et al. Further support of the role of CYP1B1 in patients with Peters anomaly. Mol Vis. 2006;12:506–10.
Mackey DA, Buttery RG, Wise GM, Denton MJ. Description of X-linked megalocornea with identification of the gene locus. Arch Ophthalmol. 1991;109:829–33.
Webb TR, Matarin M, Gardner JC, et al. X-linked megalocornea caused by mutations in CHRDL1 identifies an essential role for ventroptin in anterior segment development. Am J Hum Genet. 2012;90:247–59.
Wang P, Sun W, Li S, Xiao X, Guo X, Zhang Q. PAX6 mutations identified in 4 of 35 families with microcornea. Invest Ophthalmol Vis Sci. 2012;53:6338–42.
Harissi-Dagher M, Colby K. Anterior segment dysgenesis: Peters anomaly and sclerocornea. Int Ophthalmol Clin. 2008;48:35–42.
Elliott JH, Feman SS, O’Day DM, Garber M. Hereditary sclerocornea. Arch Ophthalmol. 1985;103:676–9.
Pantoja-Melendez C, Ali M, Zenteno JC. An epidemiological investigation of a Forkhead box protein E3 founder mutation underlying the high frequency of sclerocornea, aphakia, and microphthalmia in a Mexican village. Mol Vis. 2013;19:1866–70.
Vanathi M, Panda A, Kai S, Sen S. Corneal keloid. Ocul Surf. 2008;6:186–97.
Song E, Luo N, Alvarado JA, et al. Ocular pathology of oculocerebrorenal syndrome of Lowe: novel mutations and genotype-phenotype analysis. Sci Rep. 2017;7:1442.
Ramappa M, Chaurasia S, Chakrabarti S, Kaur I. Congenital corneal anesthesia. J AAPOS. 2014;18:427–32.
Mantelli F, Nardella C, Tiberi E, Sacchetti M, Bruscolini A, Lambiase A. Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management. Biomed Res Int. 2015;2015:805876.
Weiss JS, Moller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. Cornea. 2008;27(Suppl 2):S1–83.
Vincent AL. Corneal dystrophies and genetics in the International Committee for Classification of Corneal Dystrophies era: a review. Clin Exp Ophthalmol. 2014;42:4–12.
Boutboul S, Black GC, Moore JE, et al. A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI/BIGH3. Hum Mutat. 2006;27:553–7.
Lisch W, Bron AJ, Munier FL, et al. Franceschetti hereditary recurrent corneal erosion. Am J Ophthalmol. 2012;153:1073–81.e4.
Wittebol-Post D, van Bijsterveld OP, Delleman JW. Meesmann’s epithelial dystrophy of the cornea. Biometrics and a hypothesis. Ophthalmologica. 1987;194:44–9.
Stocker FW, Holt LB. A rare form of hereditary epithelial dystrophy of the cornea: a genetic, clinical, and pathologic study. Trans Am Ophthalmol Soc. 1954;52:133–44.
Klintworth GK. Corneal dystrophies. Orphanet J Rare Dis. 2009;4:7. https://doi.org/10.1186/1750-1172-4-7.
Alvarez-Fischer M, de Toledo JA, Barraquer RI. Lisch corneal dystrophy. Cornea. 2005;24:494–5.
Afshari NA, Mullally JE, Afshari MA, et al. Survey of patients with granular, lattice, avellino, and Reis-Bucklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch Ophthalmol. 2001;119:16–22.
Kuchle M, Green WR, Volcker HE, Barraquer J. Reevaluation of corneal dystrophies of Bowman’s layer and the anterior stroma (Reis-Bucklers and Thiel-Behnke types): a light and electron microscopic study of eight corneas and a review of the literature. Cornea. 1995;14:333–54.
Kurome H, Noda S, Hayasaka S, Setogawa T. A Japanese family with Grayson-Wilbrandt variant of Reis-Bucklers’ corneal dystrophy. Jpn J Ophthalmol. 1993;37:143–7.
Dighiero P, Niel F, Ellies P, et al. Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the TGFBI gene. Ophthalmology. 2001;108:818–23.
Afshari NA, Igo RP Jr, Morris NJ, et al. Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy. Nat Commun. 2017;8:14898.
Moller HU. Granular corneal dystrophy Groenouw type I. Clinical and genetic aspects. Acta ophthalmol Suppl. 1991;198:1–40.
Lyons CJ, McCartney AC, Kirkness CM, Ficker LA, Steele AD, Rice NS. Granular corneal dystrophy. Visual results and pattern of recurrence after lamellar or penetrating keratoplasty. Ophthalmology. 1994;101:1812–7.
Moon JW, Kim SW, Kim TI, Cristol SM, Chung ES, Kim EK. Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy): natural history and progression after treatment. Cornea. 2007;26:1095–100.
Szentmary N, Seitz B, Langenbucher A, Schlotzer-Schrehardt U, Hofmann-Rummelt C, Naumann GO. Histologic and ultrastructural changes in corneas with granular and macular dystrophy after excimer laser phototherapeutic keratectomy. Cornea. 2006;25:257–63.
Roh MI, Chung SH, Stulting RD, Kim WC, Kim EK. Preserved peripheral corneal clarity after surgical trauma in patients with Avellino corneal dystrophy. Cornea. 2006;25:497–8.
Klintworth GK, Smith CF, Bowling BL. CHST6 mutations in North American subjects with macular corneal dystrophy: a comprehensive molecular genetic review. Mol Vis. 2006;12:159–76.
Jiao X, Munier FL, Schorderet DF, et al. Genetic linkage of Francois-Neetens fleck (mouchetee) corneal dystrophy to chromosome 2q35. Hum Genet. 2003;112:593–9.
Li S, Tiab L, Jiao X, et al. Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy. Am J Hum Genet. 2005;77:54–63.
Weiss JS. Schnyder’s dystrophy of the cornea. A Swede-Finn connection. Cornea. 1992;11:93–101.
Weiss JS. Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:616–48.
Bredrup C, Knappskog PM, Majewski J, Rodahl E, Boman H. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci. 2005;46:420–6.
Johnson AT, Folberg R, Vrabec MP, Florakis GJ, Stone EM, Krachmer JH. The pathology of posterior amorphous corneal dystrophy. Ophthalmology. 1990;97:104–9.
Moshegov CN, Hoe WK, Wiffen SJ, Daya SM. Posterior amorphous corneal dystrophy. A new pedigree with phenotypic variation. Ophthalmology. 1996;103:474–8.
Jiao X, Sultana A, Garg P, et al. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. J Med Genet. 2007;44:64–8.
Aldave AJ, Yellore VS, Principe AH, et al. Candidate gene screening for posterior polymorphous dystrophy. Cornea. 2005;24:151–5.
Cibis GW, Krachmer JA, Phelps CD, Weingeist TA. The clinical spectrum of posterior polymorphous dystrophy. Arch Ophthalmol. 1977;95:1529–37.
Gottsch JD, Zhang C, Sundin OH, Bell WR, Stark WJ, Green WR. Fuchs corneal dystrophy: aberrant collagen distribution in an L450W mutant of the COL8A2 gene. Invest Ophthalmol Vis Sci. 2005;46:4504–11.
Baratz KH, Tosakulwong N, Ryu E, et al. E2-2 protein and Fuchs’s corneal dystrophy. N Engl J Med. 2010;363:1016–24.
Cabral T, DiCarlo JE, Justus S, Sengillo JD, Xu Y, Tsang SH. CRISPR applications in ophthalmologic genome surgery. Curr Opin Ophthalmol. 2017;28:252–9.
Christie KA, Courtney DG, DeDionisio LA, et al. Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders. Sci Rep. 2017;7:16174.
Zhu AY, Jaskula-Ranga V, Jun AS. Gene editing as a potential therapeutic solution for fuchs endothelial corneal dystrophy: the future is clearer. JAMA Ophthalmol. 2018;136:969–70.
Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M. Gene therapy comes of age. Science (New York, NY). 2018;359:1–12.
Zhao JJ, Afshari NA. Generation of human corneal endothelial cells via in vitro ocular lineage restriction of pluripotent stem cells. Invest Ophthalmol Vis Sci. 2016;57:6878–84.
Meekins LC, Rosado-Adames N, Maddala R, Zhao JJ, Rao PV, Afshari NA. Corneal endothelial cell migration and proliferation enhanced by rho kinase (ROCK) inhibitors in in vitro and in vivo models. Invest Ophthalmol Vis Sci. 2016;57:6731–8.
Okumura N, Kinoshita S, Koizumi N. Application of rho kinase inhibitors for the treatment of corneal endothelial diseases. J Ophthalmol. 2017;2017:2646904.
He S, Li X, Chan N, Hinton DR. Review: epigenetic mechanisms in ocular disease. Mol Vis. 2013;19:665–74.
McMonnies CW. Epigenetic mechanisms might help explain environmental contributions to the pathogenesis of keratoconus. Eye Contact Lens. 2014;40:371–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Afshari, N.A., Bernhisel, A. (2020). Genetics of Corneal Disease. In: Colby, K., Dana, R. (eds) Foundations of Corneal Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-25335-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-25335-6_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25334-9
Online ISBN: 978-3-030-25335-6
eBook Packages: MedicineMedicine (R0)